| Lemon8 | 60.0 | 7 | 0 |
| LeVogue Med Spa | 57.2 | 3 | 1 |
| Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations | 40.0 | 0 | 4 |
| Advances in facial rejuvenation: Botulinum toxin A. Hyaluronic acid dermal fillers, and combination therapies--consensus recomendations. Editor's Foreword | 40.0 | 0 | 4 |
| Yahoo | 40.0 | 3 | 0 |
| Evaluation of a new hyaluronic acid dermal filler for volume restoration | 34.5 | 0 | 3 |
| Management and prevention of adverse events in esthetic interventions | 34.5 | 0 | 3 |
| Facial rejuvenation starts in the midface: three‐dimensional volumetric facial rejuvenation has beneficial effects on nontreated neighboring esthetic units | 34.5 | 0 | 3 |
| Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin a injection alone: a split‐face, rater‐blinded, randomized control trial | 34.5 | 0 | 3 |
| The Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds: A Multicenter, Randomized Clinical Study | 34.5 | 0 | 3 |
| A novel, multistep, combination facial rejuvenation procedure for treatment of the whole face with incobotulinumtoxinA, and two dermal fillers- calcium hydroxylapatite and a monophasic, polydensified hyaluronic acid filler | 34.5 | 0 | 3 |
| Hyaluronic acid fillers and botulinum toxin type a: rationale for their individual and combined use for injectable facial rejuvenation | 34.5 | 0 | 3 |
| Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler | 34.5 | 0 | 3 |
| Body experience and self-esteem after minimally invasive skin rejuvenation : Study of female patients using botulinum toxin A and/or dermal fillers | 34.5 | 0 | 3 |
| Multicenter, Randomized, Parallel-Group Study of the Safety and Effectiveness of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24-mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial Rejuvenation | 34.5 | 0 | 3 |
| Multicenter, Randomized, Parallel-Group Study of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24-mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial Rejuvenation: Satisfaction and Patient-Reported Outcomes | 34.5 | 0 | 3 |
| Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin | 34.5 | 0 | 3 |
| Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines | 34.5 | 0 | 3 |
| Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers | 34.5 | 0 | 3 |
| Open, Non-Comparative Study To Evaluate The Performance Of The Medical Device JANESSE® | 34.5 | 0 | 3 |
| MD Auralia (HA Filler) in Treatment of Nasolabial Wrinkles | 34.5 | 0 | 3 |
| The minimally invasive rhinoplasty with hyaluronic acid and botulinum toxin in a 49-year old woman | 34.5 | 0 | 3 |
| Rhinoplasty and dermal fillers | 34.5 | 0 | 3 |
| Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines (2010-09-01) | 34.5 | 0 | 3 |
| Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers | 34.5 | 0 | 3 |
| Groupon | 31.7 | 2 | 0 |
| American Academy of Facial Plastic and Reconstructive Surgery | 31.7 | 2 | 0 |
| Center for Drug Evaluation and Research | 31.7 | 2 | 0 |
| Wexner Medical Center at Ohio State University | 31.7 | 2 | 0 |
| HealthGrades | 31.7 | 2 | 0 |
| Advanced Dermatology & Cosmetic Surgery | 31.7 | 2 | 0 |
| Cosmetic Laser Dermatology | 31.7 | 2 | 0 |
| Ohio State University Hospital | 31.7 | 2 | 0 |
| Q96602914 | 31.7 | 2 | 0 |
| WebMD Magazine | 31.7 | 2 | 0 |
| American Academy of Facial Plastic and Reconstructive Surgery | 31.7 | 2 | 0 |
| dermal fillers | 27.3 | 0 | 2 |
| Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle | 27.3 | 0 | 2 |
| Glans Penis Augmentation Using Hyaluronic Acid Gel as an Injectable Filler | 27.3 | 0 | 2 |
| Patient factors influencing dermal filler complications: prevention, assessment, and treatment | 27.3 | 0 | 2 |
| Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Complications of Injectable Fillers, Part 2: Vascular Complications | 27.3 | 0 | 2 |
| Do you know where your fillers go? An ultrastructural investigation of the lips | 27.3 | 0 | 2 |
| Minimally Invasive Facial Rejuvenation Endolaser Mid-Face Lift | 27.3 | 0 | 2 |
| Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations | 27.3 | 0 | 2 |
| Minimally invasive KTP laser treatment of perennial allergic rhinitis: a preliminary report. | 27.3 | 0 | 2 |
| ACP gel: a new hyaluronic acid-based injectable for facial rejuvenation. Preclinical data in a rabbit model | 27.3 | 0 | 2 |
| Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation | 27.3 | 0 | 2 |
| Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study | 27.3 | 0 | 2 |
| Minimally invasive treatment for varicose veins: a review of endovenous laser treatment and radiofrequency ablation | 27.3 | 0 | 2 |
| Laser peel: facial rejuvenation with a superficial erbium:YAG laser treatment | 27.3 | 0 | 2 |
| Brow suspension, a minimally invasive technique in facial rejuvenation | 27.3 | 0 | 2 |
| Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study. | 27.3 | 0 | 2 |
| Hyaluronic acid fillers in facial rejuvenation | 27.3 | 0 | 2 |
| Juvéderm: a hyaluronic acid dermal filler. | 27.3 | 0 | 2 |
| Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. | 27.3 | 0 | 2 |
| The science of hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Advances in minimally invasive facial rejuvenation | 27.3 | 0 | 2 |
| GaAs laser treatment of bilateral eyelid ptosis due to complication of botulinum toxin type A injection | 27.3 | 0 | 2 |
| Effect of multisyringe hyaluronic acid facial rejuvenation on perceived age. | 27.3 | 0 | 2 |
| Novel minimally invasive laser treatment of urinary incontinence in women | 27.3 | 0 | 2 |
| Persistence of Nasolabial Fold Correction with a Hyaluronic Acid Dermal Filler with Retreatment: Results of an 18-Month Extension Study | 27.3 | 0 | 2 |
| Effectiveness evaluation of two volumizing hyaluronic acid dermal fillers in a controlled, randomized, double-blind, split-face clinical study | 27.3 | 0 | 2 |
| Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study | 27.3 | 0 | 2 |
| Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment | 27.3 | 0 | 2 |
| Severe Acute Local Reactions to a Hyaluronic Acid-derived Dermal Filler. | 27.3 | 0 | 2 |
| A prospective, open‐label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips | 27.3 | 0 | 2 |
| Neodymium:YAG laser treatment of lower leg telangiectasia: a new minimally invasive approach. | 27.3 | 0 | 2 |
| Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures | 27.3 | 0 | 2 |
| A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity | 27.3 | 0 | 2 |
| Minimally invasive botulinum toxin type A injection from the ocular surface to extraocular muscles | 27.3 | 0 | 2 |
| Lymphedema Fat Graft: An Ideal Filler for Facial Rejuvenation | 27.3 | 0 | 2 |
| Botulinum toxin (botox) chemodenervation for facial rejuvenation. | 27.3 | 0 | 2 |
| “Home of Younger Skin” (HOYS) program: Defining the change in apparent skin age after facial treatment with botulinum toxin and dermal fillers | 27.3 | 0 | 2 |
| A skincare containing retinol adenosine and hyaluronic acid optimises the benefits from a type A botulinum toxin injection | 27.3 | 0 | 2 |
| Botulinum toxin type B: a new injectable treatment for cervical dystonia | 27.3 | 0 | 2 |
| Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers | 27.3 | 0 | 2 |
| Knowledge and attitude of dentists towards the use of botulinum toxin and dermal fillers in dentistry, Riyadh, Saudi Arabia. | 27.3 | 0 | 2 |
| A Review of the Metabolism of 1,4-Butanediol Diglycidyl Ether-Crosslinked Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration? | 27.3 | 0 | 2 |
| Recovery of calf muscle strength following acute achilles tendon rupture treatment: a comparison between minimally invasive surgery and conservative treatment | 27.3 | 0 | 2 |
| Cosmetic eyelid surgery | 27.3 | 0 | 2 |
| A prospective, observational study of the volumizing effect of open-label aesthetic use of Juvéderm®VOLUMA®with Lidocaine in mid-face area | 27.3 | 0 | 2 |
| The life cycles and biological end pathways of dermal fillers | 27.3 | 0 | 2 |
| Laser treatment of giant xanthelasma palpebrarum | 27.3 | 0 | 2 |
| Prospective Randomized Controlled Study to Determine the Effect of Topical Application of Botulinum Toxin A for Crow's Feet After Treatment With Ablative Fractional CO2 Laser | 27.3 | 0 | 2 |
| Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines | 27.3 | 0 | 2 |
| Analysis of therapeutic methods for treating vocal process granulomas | 27.3 | 0 | 2 |
| Ocular adverse effects after facial cosmetic procedures: a review of case reports | 27.3 | 0 | 2 |
| Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines | 27.3 | 0 | 2 |
| Injectable agents for facial rejuvenation: botulinum toxin and dermal filling agents | 27.3 | 0 | 2 |
| Management of Extra-Capsular Temporo-Mandibular Joint Ankylosis: Does Conservative Approach to Treatment Have a Role? | 27.3 | 0 | 2 |
| A comparison of the efficacy, safety, and longevity of two different hyaluronic acid dermal fillers in the treatment of severe nasolabial folds: a multicenter, prospective, randomized, controlled, single-blind, within-subject study | 27.3 | 0 | 2 |
| Facial rejuvenation using botulinum toxin A: review and updates | 27.3 | 0 | 2 |
| Complications of botulinum toxin A use in facial rejuvenation | 27.3 | 0 | 2 |
| The aging face in patients of color: minimally invasive surgical facial rejuvenation-a targeted approach | 27.3 | 0 | 2 |
| Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women—a pilot study | 27.3 | 0 | 2 |
| Biopolymeric agents for skin wrinkle treatment | 27.3 | 0 | 2 |
| Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper–GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation) | 27.3 | 0 | 2 |
| Combining Microfocused Ultrasound With Botulinum Toxin and Temporary and Semi-Permanent Dermal Fillers: Safety and Current Use. | 27.3 | 0 | 2 |
| Optical clearing of vaginal tissues, ex vivo, for minimally invasive laser treatment of female stress urinary incontinence | 27.3 | 0 | 2 |
| Botulinum toxin - an update on its use in facial rejuvenation | 27.3 | 0 | 2 |
| Combination of chemical peelings with botulinum toxin injections and dermal fillers | 27.3 | 0 | 2 |
| From frown lines to fissures: therapeutic uses for botulinum toxin. | 27.3 | 0 | 2 |
| Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment | 27.3 | 0 | 2 |
| A new minimally invasive mesotherapy technique for facial rejuvenation | 27.3 | 0 | 2 |
| A Randomized, Evaluator-Blinded, Split-Face Comparison Study of the Efficacy and Safety of a Novel Mannitol Containing Monophasic Hyaluronic Acid Dermal Filler for the Treatment of Moderate to Severe Nasolabial Folds | 27.3 | 0 | 2 |
| Combined treatment with botulinum toxin and hyaluronic acid to correct unsightly lateral-chin depression* | 27.3 | 0 | 2 |
| Treatment of the humeral shaft fractures--minimally invasive osteosynthesis with bridge plate versus conservative treatment with functional brace: study protocol for a randomised controlled trial | 27.3 | 0 | 2 |
| Perioral rejuvenation: restoration of attractiveness in aging females by minimally invasive procedures | 27.3 | 0 | 2 |
| STYLAGE®: a range of hyaluronic acid dermal fillers containing mannitol. Physical properties and review of the literature | 27.3 | 0 | 2 |
| Comparative physical properties of hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis | 27.3 | 0 | 2 |
| Safety and Efficacy of Facial Rejuvenation with Small Gel Particle Hyaluronic Acid with Lidocaine and AbobotulinumtoxinA in Post-Chemotherapy Patients: A Phase IV Investigator-initiated Study | 27.3 | 0 | 2 |
| Botulinum toxin in facial rejuvenation: an update | 27.3 | 0 | 2 |
| Dermal fillers and combinations of fillers for facial rejuvenation | 27.3 | 0 | 2 |
| The science and art of hyaluronic acid dermal filler use in esthetic applications | 27.3 | 0 | 2 |
| Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction | 27.3 | 0 | 2 |
| Update on botulinum toxin and dermal fillers | 27.3 | 0 | 2 |
| Volumizing with a 20-mg/mL Smooth, Highly Cohesive, Viscous Hyaluronic Acid Filler and Its Role in Facial Rejuvenation Therapy | 27.3 | 0 | 2 |
| What are the necessary practice competencies for two providers: dermal fillers and botulinum toxin type A injections? | 27.3 | 0 | 2 |
| The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic pract | 27.3 | 0 | 2 |
| The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Clinical resistance to three types of botulinum toxin type A in aesthetic medicine | 27.3 | 0 | 2 |
| Use of Fillers in Rhinoplasty | 27.3 | 0 | 2 |
| Injectable Filler Techniques for Facial Rejuvenation, Volumization, and Augmentation | 27.3 | 0 | 2 |
| Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face | 27.3 | 0 | 2 |
| Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis | 27.3 | 0 | 2 |
| Lip Injection Techniques Using Small-Particle Hyaluronic Acid Dermal Filler | 27.3 | 0 | 2 |
| Evaluation of headache relief with cosmetic onabotulinumtoxinA injections | 27.3 | 0 | 2 |
| Intra-Articular Hyaluronic Acid Compared to Traditional Conservative Treatment in Dogs with Osteoarthritis Associated with Hip Dysplasia | 27.3 | 0 | 2 |
| A case of diffuse alveolar hemorrhage associated with hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Noninferiority of IncobotulinumtoxinA, Free from Complexing Proteins, Compared with Another Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines | 27.3 | 0 | 2 |
| Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach | 27.3 | 0 | 2 |
| Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties | 27.3 | 0 | 2 |
| The Efficacy and Safety of Fractional CO2Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study | 27.3 | 0 | 2 |
| Foreign Body Granulomas after the Use of Dermal Fillers: Pathophysiology, Clinical Appearance, Histologic Features, and Treatment | 27.3 | 0 | 2 |
| Radiofrequency waves with filling and peeling substances: An innovative minimally invasive technique for facial rejuvenation | 27.3 | 0 | 2 |
| Minimally invasive, endovenous laser treatment of varicose veins in patients with von Willebrand disease | 27.3 | 0 | 2 |
| Transient superior oblique paresis after injection of Botulinum Toxin A for facial rejuvenation. | 27.3 | 0 | 2 |
| Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration | 27.3 | 0 | 2 |
| The Emervel French survey: a prospective real-practice descriptive study of 1,822 patients treated for facial rejuvenation with a new hyaluronic acid filler | 27.3 | 0 | 2 |
| Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid | 27.3 | 0 | 2 |
| Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives | 27.3 | 0 | 2 |
| Accordion Wrinkle Treatment Through the Targeted Use of Botulinum Toxin Injections | 27.3 | 0 | 2 |
| A Prospective, Split-Face, Randomized, Comparative Study of Safety and 12-Month Longevity of Three Formulations of Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds | 27.3 | 0 | 2 |
| Rheological properties of cross-linked hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Safety and efficacy of hyaluronic acid for the correction of nasolabial folds: A meta-analysis | 27.3 | 0 | 2 |
| Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers | 27.3 | 0 | 2 |
| Pins and needles: minimally invasive office techniques for facial rejuvenation | 27.3 | 0 | 2 |
| Novel synthetic dermal fillers based on sodium carboxymethylcellulose: comparison with crosslinked hyaluronic acid-based dermal fillers | 27.3 | 0 | 2 |
| Clinical introduction to the hyaluronic acid dermal filler using cohesive polydensified matrix technology. Foreword | 27.3 | 0 | 2 |
| Use of hyaluronic acid filler and botulinum toxin type A in facial renjuvenation | 27.3 | 0 | 2 |
| Botulinum toxin type A reconstituted in lidocaine with epinephrine for facial rejuvenation: results of a participant satisfaction survey | 27.3 | 0 | 2 |
| Tailored botulinum toxin type A injections in aesthetic medicine: consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone | 27.3 | 0 | 2 |
| Hyaluronic acid microneedle patch for the improvement of crow's feet wrinkles | 27.3 | 0 | 2 |
| Botulinum Toxin in Aesthetic Medicine: Myths and Realities | 27.3 | 0 | 2 |
| A prospective, comparative survey to investigate practitioners’ satisfaction with a cohesive, polydensified‐matrix®, hyaluronic acid‐based filler gel with and without lidocaine for the treatment of facial wrinkles | 27.3 | 0 | 2 |
| Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Midface | 27.3 | 0 | 2 |
| Facial dynamics and emotional expressions in facial aging treatments | 27.3 | 0 | 2 |
| Relevant anatomy for botulinum toxin facial rejuvenation | 27.3 | 0 | 2 |
| Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience | 27.3 | 0 | 2 |
| A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial | 27.3 | 0 | 2 |
| The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation | 27.3 | 0 | 2 |
| The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet Botulinum toxin type A chemodenervation | 27.3 | 0 | 2 |
| Sixth nerve palsy following botulinum toxin injection for facial rejuvenation | 27.3 | 0 | 2 |
| Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face | 27.3 | 0 | 2 |
| Clinical evaluation of a cross-linked hyaluronic Acid dermal filler applied for facial augmentation | 27.3 | 0 | 2 |
| An innovative method to quantitate tissue integration of hyaluronic acid-based dermal fillers. | 27.3 | 0 | 2 |
| Hyaluronic acid fat graft myringoplasty: A minimally invasive technique | 27.3 | 0 | 2 |
| A Randomized Clinical Trial of Comparing Monophasic Monodensified and Biphasic Nonanimal Stabilized Hyaluronic Acid Dermal Fillers in Treatment of Asian Nasolabial Folds | 27.3 | 0 | 2 |
| A new dermal filler made of cross‐linked and auto‐cross‐linked hyaluronic acid in the correction of facial aging defects | 27.3 | 0 | 2 |
| Minimally invasive treatment of dynamic horizontal forehead lines | 27.3 | 0 | 2 |
| Sustained efficacy and high patient satisfaction after cheek enhancement with a new hyaluronic acid dermal filler. | 27.3 | 0 | 2 |
| Facial Rejuvenation Enhancing Cheek Lift | 27.3 | 0 | 2 |
| The cost effectiveness analysis of minimally invasive surgery and conservative treatment in elderly osteoporotic spinal fracture | 27.3 | 0 | 2 |
| Minimally Invasive Bio-Rejuvenation Dentistry: A Conservative Approach to Full-Mouth Rehabilitation | 27.3 | 0 | 2 |
| Botulinum toxin: An important complement for facial rejuvenation surgery | 27.3 | 0 | 2 |
| Hyaluronic Acid and Other Conservative Treatment Options for Osteoarthritis of the Ankle | 27.3 | 0 | 2 |
| Dermoscopy Study on the Effects of Gold Microacupuncture,Hyaluronic Acid Injection,and rb-bFGF to Treat Facial Rejuvenation | 27.3 | 0 | 2 |
| Benefits of volumetric to facial rejuvenation. Part 2: Dermal fillers | 27.3 | 0 | 2 |
| Anatomy-based image processing analysis of the running pattern of the perioral artery for minimally invasive surgery | 27.3 | 0 | 2 |
| Lateral oblique forehead lines: redefining sleeping lines and treatment with botulinum toxin A | 27.3 | 0 | 2 |
| A Split-Face Assessment of the Synergistic Potential of Sequential Q-Switched Nd:YAG Laser and 1565 nm Fractional Nonablative Laser Treatment for Facial Rejuvenation in Fitzpatrick Skin Type II-V Patients | 27.3 | 0 | 2 |
| Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler | 27.3 | 0 | 2 |
| Long-lasting and bioactive hyaluronic acid-hydroxyapatite composite hydrogels for injectable dermal fillers: Physical properties and in vivo durability. | 27.3 | 0 | 2 |
| A guide to temporal fossa augmentation with small gel particle hyaluronic acid dermal filler | 27.3 | 0 | 2 |
| Minimally invasive fixation versus conservative treatment of undisplaced scaphoid fractures: a cost-effectiveness study | 27.3 | 0 | 2 |
| Consensus Recommendations for Treatment Strategies in Indians Using Botulinum Toxin and Hyaluronic Acid Fillers | 27.3 | 0 | 2 |
| Randomized, Patient/Evaluator-Blinded, Intraindividual Comparison Study to Evaluate the Efficacy and Safety of a Novel Hyaluronic Acid Dermal Filler in the Treatment of Nasolabial Folds | 27.3 | 0 | 2 |
| Multiple microneedling sessions for minimally invasive facial rejuvenation: an objective assessment | 27.3 | 0 | 2 |
| The Efficacy and Safety of Liquid-Type Botulinum Toxin Type A for the Management of Moderate to Severe Glabellar Frown Lines | 27.3 | 0 | 2 |
| Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet | 27.3 | 0 | 2 |
| Use of AccuVein™ for preventing complications from accidental venipuncture when administering dermal filler injections | 27.3 | 0 | 2 |
| The reconstructed skin model as a new tool for investigating in vitro dermal fillers: increased fibroblast activity by hyaluronic acid | 27.3 | 0 | 2 |
| Prospective Randomized Split-Face Comparative Study Between Topical Botulinum Toxin A Surface Application and Local Injection for Crow's Feet | 27.3 | 0 | 2 |
| Minimally Invasive Dentistry: A Conservative Approach to Smile Makeover | 27.3 | 0 | 2 |
| Safety and Effectiveness of the Hyaluronic Acid Dermal Filler VYC-17.5L for Nasolabial Folds: Results of a Randomized, Controlled Study. | 27.3 | 0 | 2 |
| Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial | 27.3 | 0 | 2 |
| Hyaluronic acid dermal fillers in the management of recurrent angular cheilitis: A case report. | 27.3 | 0 | 2 |
| Commentary on a Randomized Clinical Trial of Comparing Monophasic Monodensified and Biphasic Nonanimal Stabilized Hyaluronic Acid Dermal Fillers in Treatment of Asian Nasolabial Folds | 27.3 | 0 | 2 |
| Can ultraviolet rays induce a granulomatous reaction after hyaluronic acid dermal filler injections? | 27.3 | 0 | 2 |
| Late-Onset Inflammatory Response to Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks? | 27.3 | 0 | 2 |
| Efficacy of autologous platelet-rich plasma combined with hyaluronic acid on skin facial rejuvenation: A prospective study | 27.3 | 0 | 2 |
| Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study | 27.3 | 0 | 2 |
| Cell‐adhesive thermogelling PNIPAAm/hyaluronic acid cell delivery hydrogels for potential application as minimally invasive retinal therapeutics | 27.3 | 0 | 2 |
| Three-Dimensional Evaluation of Static and Dynamic Effects of Botulinum Toxin A on Glabellar Frown Lines | 27.3 | 0 | 2 |
| Rheology of hyaluronic acid and dynamic facial rejuvenation: Topographical specificities | 27.3 | 0 | 2 |
| Advanced Material Catheter (AMCath), a minimally invasive endocardial catheter for the delivery of fast-gelling covalently cross-linked hyaluronic acid hydrogels | 27.3 | 0 | 2 |
| Minimally Invasive Craniopuncture Therapy vs. Conservative Treatment for Spontaneous Intracerebral Hemorrhage: Results from a Randomized Clinical Trial in China | 27.3 | 0 | 2 |
| Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT) | 27.3 | 0 | 2 |
| A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management | 27.3 | 0 | 2 |
| Brain functional changes in patients with botulism after illegal cosmetic injections of botulinum toxin: A resting-state fMRI study | 27.3 | 0 | 2 |
| Treatment of facial lipoatrophy, morphological asymmetry, or debilitating scars with the hyaluronic acid dermal filler Princess FILLER | 27.3 | 0 | 2 |
| Safety and effectiveness of hyaluronic acid dermal filler in correction of moderate-to-severe nasolabial folds in Chinese subjects | 27.3 | 0 | 2 |
| Comparison of Safety and Efficacy of a Metallic Cannula Versus a Standard Needle to Inject Hyaluronic Acid for Nasolabial Fold | 27.3 | 0 | 2 |
| Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation | 27.3 | 0 | 2 |
| Botox Injection for Treatment of Vaginismus | 27.3 | 0 | 2 |
| Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines | 27.3 | 0 | 2 |
| Assessing Cervical Dystonia | 27.3 | 0 | 2 |
| Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression Lines | 27.3 | 0 | 2 |
| Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines | 27.3 | 0 | 2 |
| Minimally Invasive Laser Treatment of Ureterocele | 27.3 | 0 | 2 |
| Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illness | 27.3 | 0 | 2 |
| Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines | 27.3 | 0 | 2 |
| Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines | 27.3 | 0 | 2 |
| Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema | 27.3 | 0 | 2 |
| Botox Injection in Treatment of Cluster Headache | 27.3 | 0 | 2 |
| Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | 27.3 | 0 | 2 |
| A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides | 27.3 | 0 | 2 |
| Botox Injection in Treatment of Chronic Migraine | 27.3 | 0 | 2 |
| Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines | 27.3 | 0 | 2 |
| Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | 27.3 | 0 | 2 |
| Collagen Injections for the Treatment of Acne Scars and Wrinkles | 27.3 | 0 | 2 |
| Pan Facial Volume Restoration | 27.3 | 0 | 2 |
| Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone | 27.3 | 0 | 2 |
| NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines | 27.3 | 0 | 2 |
| Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows | 27.3 | 0 | 2 |
| Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows | 27.3 | 0 | 2 |
| Botox Injections for Patients With Persistent Facial Pain | 27.3 | 0 | 2 |
| Minimally Invasive Volume Augmentation of Papillae Around Implant Restorations With Hyaluronic Acid Injection | 27.3 | 0 | 2 |
| Volume Restoration of Plantar Pad With a Hyaluronic Acid Dermal Filler in Metatarsalgia | 27.3 | 0 | 2 |
| Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines | 27.3 | 0 | 2 |
| Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome | 27.3 | 0 | 2 |
| Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds | 27.3 | 0 | 2 |
| Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy | 27.3 | 0 | 2 |
| Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer | 27.3 | 0 | 2 |
| Hyaluronic Acid in Papillary Reconstruction | 27.3 | 0 | 2 |
| Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | 27.3 | 0 | 2 |
| Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With Regen-Kit BCT-HA in Aesthetic Medicine | 27.3 | 0 | 2 |
| The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Intraoperative Injection of Botulinum Toxin A into Orbicularis Oculi Muscle for the Treatment of Crow's Feet | 27.3 | 0 | 2 |
| Botulinum toxin B: the new option in cosmetic injection | 27.3 | 0 | 2 |
| Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow's feet | 27.3 | 0 | 2 |
| Botulinum toxin (Botox Cosmetic) for frown lines | 27.3 | 0 | 2 |
| Evaluate The Performance And Safety Of The Medical Device Jalucomplex® | 27.3 | 0 | 2 |
| Two-plane injection of botulinum toxin for the treatment of glabellar frown lines | 27.3 | 0 | 2 |
| Minimally Invasive Application of Botulinum Toxin Type A in Nasal Hypersecretion | 27.3 | 0 | 2 |
| Botulinum toxin type A injection for the treatment of frown lines | 27.3 | 0 | 2 |
| Intraoperative Injection of Botulinum Toxin A into the Orbicularis Oculi Muscle for the Treatment of Crow???s Feet | 27.3 | 0 | 2 |
| [Rational minimally invasive treatment of pAOD: when should a conservative approach, PTA, or stent be chosen?] | 27.3 | 0 | 2 |
| [Consensus recommendations on the use of botulinum toxin type A in aesthetic medicine] | 27.3 | 0 | 2 |
| In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin | 27.3 | 0 | 2 |
| A new minimally invasive procedure for the conservative treatment of uterine prolapse--the posterior IVS | 27.3 | 0 | 2 |
| Botox injections for lower facial rejuvenation | 27.3 | 0 | 2 |
| Head-to-head studies of botulinum toxin A in aesthetic medicine: which evidence is good enough? | 27.3 | 0 | 2 |
| Soft tissue augmentation--use of hyaluronic acid as dermal filler | 27.3 | 0 | 2 |
| Complications of botulinum toxin A use in facial rejuvenation | 27.3 | 0 | 2 |
| Complications with the use of botulinum toxin type a in facial rejuvenation: report of 8 cases | 27.3 | 0 | 2 |
| Botulinum toxin injections for facial rejuvenation | 27.3 | 0 | 2 |
| A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity | 27.3 | 0 | 2 |
| A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity | 27.3 | 0 | 2 |
| Monophasic dermal filler based on hyaluronic acid: a new era of tissue augmentation--introduction to the topic | 27.3 | 0 | 2 |
| Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet | 27.3 | 0 | 2 |
| Medical rhinoplasty with hyaluronic acid and botulinum toxin A: a very simple and quite effective technique | 27.3 | 0 | 2 |
| Visual field defect after facial rejuvenation with botulinum toxin type A and polyacrylamide hydrogel injection | 27.3 | 0 | 2 |
| Commentary: rheological evaluation of the physical properties of hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Rheological evaluation of the physical properties of hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Conservative treatment of breast carcinoma in small breasts: new minimally invasive surgical technique | 27.3 | 0 | 2 |
| Botulinum Toxin in Facial Rejuvenation: An Update | 27.3 | 0 | 2 |
| Comparison of Two Botulinum Toxin Type A Preparations for Treating Crow's Feet: A Split-Face, Double-Blind, Proof-of-Concept Study | 27.3 | 0 | 2 |
| Are medical spas violating the practice of medicine statute with botox injections? | 27.3 | 0 | 2 |
| A minimally invasive temporary cavernoso-saphenous shunt in the management of priapism after failed conservative treatment | 27.3 | 0 | 2 |
| Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation | 27.3 | 0 | 2 |
| Near-Infrared Imaging of Veins in Facial Injection of Botulinum Toxin and Hyaluronic Acid | 27.3 | 0 | 2 |
| Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique | 27.3 | 0 | 2 |
| Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines - 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study | 27.3 | 0 | 2 |
| Phosphatidylcholine/deoxycholate lipolysis and hyaluronic acid augmentation to enhance nonsurgical lower facial contouring using botulinum toxin type A | 27.3 | 0 | 2 |
| Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study | 27.3 | 0 | 2 |
| Gel Properties of Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Hyaluronic Acid dermal filler for the treatment of oral incompetence | 27.3 | 0 | 2 |
| Juvéderm emerges as the newest hyaluronic acid dermal filler | 27.3 | 0 | 2 |
| The Shift Toward Minimally Invasive Aesthetic Facial Rejuvenation | 27.3 | 0 | 2 |
| Novel Hyaluronic Acid Dermal Filler: Dermal Gel Extra Physical Properties and Clinical Outcomes | 27.3 | 0 | 2 |
| Clinical guideline of the dermal filler of hyaluronic acid | 27.3 | 0 | 2 |
| A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler | 27.3 | 0 | 2 |
| Skin Extracellular Matrix Stimulation following Injection of a Hyaluronic Acid–Based Dermal Filler in a Rat Model | 27.3 | 0 | 2 |
| Update on hyaluronic acid fillers for facial rejuvenation | 27.3 | 0 | 2 |
| The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic | 27.3 | 0 | 2 |
| A composite dermal filler comprising cross-linked hyaluronic acid and human collagen for tissue reconstruction | 27.3 | 0 | 2 |
| Optimal dosage of botulinum toxin type A for treatment of glabellar frown lines: efficacy and safety in a clinical trial | 27.3 | 0 | 2 |
| Lupus erythematosus panniculitis–induced facial atrophy: Effective treatment with poly-L-lactic acid and hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Multicenter Randomized Study of Obesity Treatment with Minimally Invasive Injection of Hyaluronic Acid Versus and Combined with Intragastric Balloon | 27.3 | 0 | 2 |
| Commentary to “Effect of Botox injection at the bladder neck in boys with bladder dysfunction after valve ablation” | 27.3 | 0 | 2 |
| Notice of Retraction: Pak CS, et al. A Phase III, Randomized, Double-Blind, Matched-Pairs, Active-Controlled Clinical Trial and Preclinical Animal Study to Compare the Durability, Efficacy and Safety between Polynucleotide Filler and Hyaluronic Acid | 27.3 | 0 | 2 |
| Late-Onset Adverse Reactions Related to Hyaluronic Acid Dermal Filler for Aesthetic Soft Tissue Augmentation | 27.3 | 0 | 2 |
| A novel facial rejuvenation treatment using pneumatic injection of non-cross-linked hyaluronic acid and hypertonic glucose solution | 27.3 | 0 | 2 |
| Use of hyaluronidase to correct hyaluronic acid injections in aesthetic medicine | 27.3 | 0 | 2 |
| New minimally invasive technique for cystoscopic laser treatment of fetal ureterocele | 27.3 | 0 | 2 |
| Intralesional Laser Treatment for Dermal Filler Complications | 27.3 | 0 | 2 |
| An objective method to assess the improvements of skin texture roughness after botulinum toxin type a treatment of crow's feet | 27.3 | 0 | 2 |
| Body Image, Personality Traits, and Quality of Life in Botulinum Toxin A and Dermal Filler Patients | 27.3 | 0 | 2 |
| The Expanding Market of Health Canada-Approved Hyaluronic Acid-Injectable Dermal Fillers | 27.3 | 0 | 2 |
| [Hyaluronic acid rheology: Basics and clinical applications in facial rejuvenation] | 27.3 | 0 | 2 |
| A high crosslinking grade of hyaluronic acid found in a dermal filler causing adverse effects | 27.3 | 0 | 2 |
| Facial rejuvenation using photodynamic therapy with a novel preparation of ALA and hyaluronic acid in young adults | 27.3 | 0 | 2 |
| Mouth Corner Lift with Botulinum Toxin Type A and Hyaluronic Acid Filler | 27.3 | 0 | 2 |
| Using Google to Trend Patient Interest in Botulinum Toxin and Hyaluronic Acid Fillers | 27.3 | 0 | 2 |
| Straight-Line Vector Planning for Optimal Results With Silhouette InstaLift in Minimally Invasive Tissue Repositioning for Facial Rejuvenation | 27.3 | 0 | 2 |
| Correction to: Concomitant Use of Hyaluronic Acid and Laser in Facial Rejuvenation | 27.3 | 0 | 2 |
| Minimally invasive Venetian blinds ventral hernia repair with botulinum toxin chemical component separation | 27.3 | 0 | 2 |
| Cosmetic Injection of Botulinum Toxin Unmasking Subclinical Myasthenia Gravis: A Case Report and Literature Review | 27.3 | 0 | 2 |
| Comparative Evaluation of the Effectiveness of Novel Hyaluronic Acid-Polynucleotide Complex Dermal Filler | 27.3 | 0 | 2 |
| A Comparative In Vivo Study on Three Treatment Approaches to Applying Topical Botulinum Toxin A for Crow's Feet | 27.3 | 0 | 2 |
| Impact of Botulinum Toxin Type A Treatment of the Glabella and Crow's Feet on Static Forehead Rhytides | 27.3 | 0 | 2 |
| Osteoarthritis of the hip conservative treatment with type A botulinum toxin | 27.3 | 0 | 2 |
| The Impact of Upper Face Botulinum Toxin Injections on Eyebrow Height and Forehead Lines: A Randomized Controlled Trial and an Algorithmic Approach to Forehead Injection | 27.3 | 0 | 2 |
| Combining microneedling with other minimally invasive procedures for facial rejuvenation: a split-face comparative study | 27.3 | 0 | 2 |
| A randomized, patient/evaluator-blinded, split-face study to compare the efficacy and safety of polycaprolactone and polynucleotide fillers in the correction of crow's feet: The latest biostimulatory dermal filler for crow's feet | 27.3 | 0 | 2 |
| Minimally invasive approaches to axillary osmidrosis treatment: A comparison between superficial liposuction with automatic shaver curettage, subcutaneous laser treatment, and microwave-based therapy with a modified technique | 27.3 | 0 | 2 |
| Minimally Invasive Rhinoplasty Technique Using a Hyaluronic Acid Filler and Polydioxanone Threads: An Effective Combination | 27.3 | 0 | 2 |
| Minimally invasive erbium laser treatment for selected snorers | 27.3 | 0 | 2 |
| Delayed sclerosing granulomatous reaction to dermal filler injection of poly-hydroxyethyl-methacrylate suspended in hyaluronic acid: Histochemical and confocal laser scanning microscopical analysis | 27.3 | 0 | 2 |
| Rosacea-like acute reaction after hyaluronic acid dermal filler | 27.3 | 0 | 2 |
| A case of upper lip necrosis after cosmetic injection of hyaluronic acid soft-tissue filler-Does capillary infarction play a role in the development of vascular compromise, and what are the implications? | 27.3 | 0 | 2 |
| Lip and Perioral Enhancement With Hyaluronic Acid Dermal Fillers in Individuals With Skin of Color | 27.3 | 0 | 2 |
| Periarticular hypertonic dextrose vs intraarticular hyaluronic acid injections: a comparison of two minimally invasive techniques in the treatment of symptomatic knee osteoarthritis | 27.3 | 0 | 2 |
| Concomitant Use of Hyaluronic Acid and Laser in Facial Rejuvenation | 27.3 | 0 | 2 |
| Minimally invasive surgical treatment of minimally displaced acetabular fractures does not improve pain, mobility or quality of life compared to conservative treatment: a matched-pair analysis of 50 patients | 27.3 | 0 | 2 |
| Assessment of the efficacy and safety of platelet poor plasma gel as autologous dermal filler for facial rejuvenation | 27.3 | 0 | 2 |
| Demographics of Men and Minorities in Cosmetic Clinical Trials of Botulinum Toxin and Hyaluronic Acid Fillers | 27.3 | 0 | 2 |
| Increased usage of botulinum toxin and hyaluronic acid fillers in young adults | 27.3 | 0 | 2 |
| Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines | 27.3 | 0 | 2 |
| Practical Guidelines for Hyaluronic Acid Soft-Tissue Filler Use in Facial Rejuvenation | 27.3 | 0 | 2 |
| [Minimally Invasive Corrugator Resection and Backfill Using Self-made Modified Liposuction Needle in the Treatment of Moderate and Severe Glabellar Frown Lines] | 27.3 | 0 | 2 |
| Facial Rejuvenation Using a Mixture of Calcium Hydroxylapatite Filler and Hyaluronic Acid Filler | 27.3 | 0 | 2 |
| Superficial Dermal Fillers with Hyaluronic Acid | 27.3 | 0 | 2 |
| The Impact of Upper Face Botulinum Toxin Injections on Eyebrow Height and Forehead Lines: A Randomized Controlled Trial and an Algorithmic Approach to Forehead Injection " | 27.3 | 0 | 2 |
| Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate-to-severe nasolabial folds: A 64-week, prospective, multicenter, controlled, randomized, double-blind and within-subject study | 27.3 | 0 | 2 |
| Improvement of Radial Cheek Lines With Hyaluronic Acid-Based Dermal Filler VYC-17.5L: Results of the BEAM Study | 27.3 | 0 | 2 |
| Facial Contouring by Using Dermal Fillers and Botulinum Toxin A: A Practical Approach | 27.3 | 0 | 2 |
| Botulinum Toxin to Treat Horizontal Forehead Lines: A Refined Injection Pattern Accommodating the Lower Frontalis | 27.3 | 0 | 2 |
| Delayed periorbital inflammation presenting as orbital pseudotumour after hyaluronic acid dermal filler injection | 27.3 | 0 | 2 |
| Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study | 27.3 | 0 | 2 |
| Intraoperative Injection of Botulinum Toxin A into Orbicularis Oculi Muscle for the Treatment of Crow's Feet | 27.3 | 0 | 2 |
| Picosecond-Domain Fractional Laser Treatment Over Hyaluronic Acid Fillers: In Vivo and Clinical Studies | 27.3 | 0 | 2 |
| Optimizing facial rejuvenation outcomes by combining poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and neurotoxins: two case studies | 27.3 | 0 | 2 |
| Minimally invasive surgery for chronic low back pain. When conservative treatment fails, new options include MIS spine fusion, microdiscectomy, and microlaminectomy to relieve pain and restore function | 27.3 | 0 | 2 |
| Minimally Invasive Aesthetic Treatment of the Face and Neck Using Combinations of a PCL-Based Collagen Stimulator, PLLA/PLGA Suspension Sutures, and Cross-Linked Hyaluronic Acid | 27.3 | 0 | 2 |
| Management Patterns of Delayed Inflammatory Reactions to Hyaluronic Acid Dermal Fillers: An Online Survey in Israel | 27.3 | 0 | 2 |
| A Prospective Study on Safety, Complications and Satisfaction Analysis for Tear Trough Rejuvenation Using Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Reply: The Impact of Upper Face Botulinum Toxin Injections on Eyebrow Height and Forehead Lines: A Randomized Controlled Trial and an Algorithmic Approach to Forehead Injection | 27.3 | 0 | 2 |
| Facial plastic surgery & aesthetic medicine | 27.3 | 0 | 2 |
| Herpes reactivation after the injection of hyaluronic acid dermal filler: A case report and review of literature | 27.3 | 0 | 2 |
| Assessment of Evidence Regarding Minimally Invasive Surgery vs. Conservative Treatment on Intracerebral Hemorrhage: A Trial Sequential Analysis of Randomized Controlled Trials | 27.3 | 0 | 2 |
| Impact of Botox Treatment Into the Upper One Third of the Face (Glabella, Forehead Lines and/or Lateral Canthal Lines) an Area on Mood and Self -Appearance Satisfaction | 27.3 | 0 | 2 |
| The Use of Botulinum Toxin and Dermal Fillers to Enhance Patients' Perceived Attractiveness: Implications for the Future of Aesthetic Dentistry | 27.3 | 0 | 2 |
| Delayed adverse events after using two different types of hyaluronic acid-based dermal fillers | 27.3 | 0 | 2 |
| Biological Effects of Hyaluronic Acid-Based Dermal Fillers and Laser Therapy on Human Skin Models | 27.3 | 0 | 2 |
| An Italian experience of a new personalized injective protocol (Botutouch) for botulinum toxin application in aesthetic medicine | 27.3 | 0 | 2 |
| Effect of Hyaluronic Acid and Poly-L-Lactic Acid Dermal Fillers on Collagen Synthesis: An in vitro and in vivo Study | 27.3 | 0 | 2 |
| Comparing the Efficacy of Conservative Treatment With Minimally Invasive Surgery in the Treatment of Rib Fractures | 27.3 | 0 | 2 |
| In vitro toxicity assessment of crosslinking agents used in hyaluronic acid dermal filler | 27.3 | 0 | 2 |
| Commentary on Safe and Effective Chin Augmentation With a Hyaluronic Acid Injectable Filler, VYC20L | 27.3 | 0 | 2 |
| Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines. | 27.3 | 0 | 2 |
| Evaluation of Physicochemical Properties Following Syringe-to-Syringe Mixing of Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Commentary on Evaluation of Physicochemical Properties Following Syringe-to-Syringe Mixing of Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis | 27.3 | 0 | 2 |
| Conservative treatment of hip osteoarthritis; comparison between three medium/high molecular weight hyaluronic acid injections and two injections of HYADD®4: a randomized controlled double-blind study | 27.3 | 0 | 2 |
| Late onset hypersensitivity reaction to hyaluronic acid dermal fillers manifesting as cutaneous and visceral angioedema | 27.3 | 0 | 2 |
| Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L | 27.3 | 0 | 2 |
| Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy | 27.3 | 0 | 2 |
| Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina. | 27.3 | 0 | 2 |
| Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines | 27.3 | 0 | 2 |
| Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora. | 27.3 | 0 | 2 |
| Investigating Temporalis and Masseter Botox Injection Before Orthognathic Surgery to Improve Postoperative Pain | 27.3 | 0 | 2 |
| Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine | 27.3 | 0 | 2 |
| A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF) | 27.3 | 0 | 2 |
| Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects | 27.3 | 0 | 2 |
| Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects | 27.3 | 0 | 2 |
| Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects | 27.3 | 0 | 2 |
| Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor | 27.3 | 0 | 2 |
| “COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment” | 27.3 | 0 | 2 |
| Self-biomineralized in situ injectable CaSO4 nanorods-enriched collagen-hyaluronic acid composite hydrogels for biomimetic bone reconstruction in a minimally invasive manner | 27.3 | 0 | 2 |
| PhalloFill | 27.3 | 0 | 2 |
| Complications in Minimally Invasive Facial Rejuvenation: Prevention and Management P J Carniol, M M Avram, J A Brauer Thieme, 2020 ISBN 978 1 68420 013 9 pp 223 Price £126.00 | 27.3 | 0 | 2 |
| MP80-14 BOTULINUM TOXIN A: THE SHIFT TO A MINIMALLY INVASIVE MANAGEMENT OF NEUROGENIC BLADDER | 27.3 | 0 | 2 |
| Minimally Invasive Techniques for Facial Rejuvenation Utilizing Polydioxanone Threads | 27.3 | 0 | 2 |
| Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2 | 27.3 | 0 | 2 |
| Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their use | 27.3 | 0 | 2 |
| Endoscopic Ultrasound-Guided Botox Injection of Internal Anal Sphincter: A New Approach to Botox Injections for Refractory Anal Fissure | 27.3 | 0 | 2 |
| Enhancing the Cupid's bow with hyaluronic acid dermal fillers | 27.3 | 0 | 2 |
| Zygomatic Augmentation through Curved Cannulas with the Use of a New Stabilized Hyaluronic Acid Dermal Filler (Decoria voluma, Bohus BioTech AB, Sweden, EC): 10 Months Follow Up | 27.3 | 0 | 2 |
| Minimally invasive facial rejuvenation combining thread lifting with liposuction: A clinical comparison with thread lifting alone | 27.3 | 0 | 2 |
| Minimally Invasive Temporomandibular Joint Surgery Methods using Surgical Treatment of Hyaluronic Acid in Patients with Various Diseases | 27.3 | 0 | 2 |
| Invited Commentary: Analysis of Breast Milk Samples in Lactating Women After Undergoing Botulinum Toxin Injections for Facial Rejuvenation: A Pilot Study | 27.3 | 0 | 2 |
| Off-label use of a medium-high molecular weight, isotonic and sterile hyaluronic acid in aesthetic medicine. Cases report | 27.3 | 0 | 2 |
| The Superior Effect of Radiofrequency With Targeted Ultrasound for Facial Rejuvenation by Inducing Hyaluronic Acid Synthesis: A Pilot Preclinical Study | 27.3 | 0 | 2 |
| Clinical Perspectives on the Injectability of Cross-Linked Hyaluronic Acid Dermal Fillers: A Standardized Methodology for Commercial Product Benchmarking with Inter-Injector Assessments | 27.3 | 0 | 2 |
| Spacest.com | 27.3 | 0 | 2 |
| Q137186500 | 27.3 | 0 | 2 |
| Małgorzata Ornatowska-Kapera | 27.3 | 0 | 2 |
| Solas Health & Wellness | 27.3 | 0 | 2 |
| Greenwich Medical Spa | 27.3 | 0 | 2 |
| United States Food and Drug Administration | 20.0 | 1 | 0 |
| Allure | 20.0 | 1 | 0 |
| Allergan, Inc. | 20.0 | 1 | 0 |
| Galderma | 20.0 | 1 | 0 |
| Allergan plc | 20.0 | 1 | 0 |
| Sephora | 20.0 | 1 | 0 |
| WebMD | 20.0 | 1 | 0 |
| Adam Shapiro | 20.0 | 1 | 0 |
| Q4721427 | 20.0 | 1 | 0 |
| American Academy of Anti-Aging Medicine | 20.0 | 1 | 0 |
| American Academy of Dermatology | 20.0 | 1 | 0 |
| American Academy of Ophthalmology | 20.0 | 1 | 0 |
| American Society of Plastic Surgeons | 20.0 | 1 | 0 |
| Andrea Miller | 20.0 | 1 | 0 |
| Andrew Serwer | 20.0 | 1 | 0 |
| ArrayTrack | 20.0 | 1 | 0 |
| Bad Bug Book | 20.0 | 1 | 0 |
| Center for Biologics Evaluation and Research | 20.0 | 1 | 0 |
| Center for Devices and Radiological Health | 20.0 | 1 | 0 |
| Center for Food Safety and Applied Nutrition | 20.0 | 1 | 0 |
| Center for Tobacco Products | 20.0 | 1 | 0 |
| Center for Veterinary Medicine | 20.0 | 1 | 0 |
| Heyday Records | 20.0 | 1 | 0 |
| Mitchel P. Goldman | 20.0 | 1 | 0 |
| National Center for Toxicological Research | 20.0 | 1 | 0 |
| Office of Criminal Investigations | 20.0 | 1 | 0 |
| Richard M. Ross Heart Hospital | 20.0 | 1 | 0 |
| SkinCeuticals | 20.0 | 1 | 0 |
| Yahoo! Tech | 20.0 | 1 | 0 |
| Zocdoc | 20.0 | 1 | 0 |
| Veritas: Revista de Filosofía y Teología | 20.0 | 1 | 0 |
| Healthline | 20.0 | 1 | 0 |
| Dermalogica Inc. | 20.0 | 1 | 0 |
| Community, season 6 | 20.0 | 1 | 0 |
| Other Space | 20.0 | 1 | 0 |
| Dermstore | 20.0 | 1 | 0 |
| Christian Assemblies International | 20.0 | 1 | 0 |
| RealSelf | 20.0 | 1 | 0 |
| FDA medical bulletin : important information for health professionals from the U.S. Food & Drug Administration | 20.0 | 1 | 0 |
| Revista ecuatoriana de pediatria | 20.0 | 1 | 0 |
| MINDBODY | 20.0 | 1 | 0 |
| botulism | 17.2 | 0 | 1 |
| botulinum toxin group | 17.2 | 0 | 1 |
| medical director | 17.2 | 0 | 1 |
| hyaluronic acid | 17.2 | 0 | 1 |
| angioplasty | 17.2 | 0 | 1 |
| lumpectomy | 17.2 | 0 | 1 |
| What to Expect When You're Expecting | 17.2 | 0 | 1 |
| Cleveland Museum of Art | 17.2 | 0 | 1 |
| caltrop | 17.2 | 0 | 1 |
| German Society for Interventional Radiology and Minimally Invasive Therapy | 17.2 | 0 | 1 |
| Endovenous laser treatment | 17.2 | 0 | 1 |
| minimally-invasive procedures | 17.2 | 0 | 1 |
| photobiomodulation | 17.2 | 0 | 1 |
| tripundra | 17.2 | 0 | 1 |
| transanal hemorrhoidal dearterialization | 17.2 | 0 | 1 |
| Transanal hemorrhoidal dearterialization | 17.2 | 0 | 1 |
| Hyaluronan sodium | 17.2 | 0 | 1 |
| aesthetic medicine | 17.2 | 0 | 1 |
| Prostiva | 17.2 | 0 | 1 |
| Minimally invasive video-assisted thyroidectomy | 17.2 | 0 | 1 |
| Rac family small GTPase 1 | 17.2 | 0 | 1 |
| botulinum toxin type A | 17.2 | 0 | 1 |
| Minimally invasive plate metalosynthesis | 17.2 | 0 | 1 |
| EBooking | 17.2 | 0 | 1 |
| Alcohol septal ablation | 17.2 | 0 | 1 |
| Austen Riggs Center | 17.2 | 0 | 1 |
| Charles Teo | 17.2 | 0 | 1 |
| elementary key normal form | 17.2 | 0 | 1 |
| Etix | 17.2 | 0 | 1 |
| Facial rejuvenation | 17.2 | 0 | 1 |
| Fraxel | 17.2 | 0 | 1 |
| Interspinous process decompression | 17.2 | 0 | 1 |
| interventional magnetic resonance imaging | 17.2 | 0 | 1 |
| Nucleoplasty | 17.2 | 0 | 1 |
| Julio Palmaz | 17.2 | 0 | 1 |
| list of EMS provider credentials | 17.2 | 0 | 1 |
| Luther Lochman von Wedekind | 17.2 | 0 | 1 |
| MILLER banding | 17.2 | 0 | 1 |
| Medical Director of the Year Award | 17.2 | 0 | 1 |
| Minimal invasive spine surgery | 17.2 | 0 | 1 |
| Minimally Invasive Thorasic Spinal Fusion | 17.2 | 0 | 1 |
| Minimally invasive cardiac surgery | 17.2 | 0 | 1 |
| Minimally invasive hip resurfacing | 17.2 | 0 | 1 |
| Minimally invasive education | 17.2 | 0 | 1 |
| Minimally invasive warrantless search | 17.2 | 0 | 1 |
| pouchoscopy | 17.2 | 0 | 1 |
| Pulmonary angiography | 17.2 | 0 | 1 |
| Roger Sanders | 17.2 | 0 | 1 |
| rustic furniture | 17.2 | 0 | 1 |
| Platelet-rich fibrin matrix | 17.2 | 0 | 1 |
| Society of Interventional Radiology | 17.2 | 0 | 1 |
| Thomas J. Fogarty | 17.2 | 0 | 1 |
| Trabeculoplasty | 17.2 | 0 | 1 |
| transoral laser microsurgery | 17.2 | 0 | 1 |
| Vacuum-assisted breast biopsy | 17.2 | 0 | 1 |
| What to Expect When You're Expecting | 17.2 | 0 | 1 |
| ZEUS robotic surgical system | 17.2 | 0 | 1 |
| Solanka Park in Inowrocław | 17.2 | 0 | 1 |
| day spa | 17.2 | 0 | 1 |
| viscosupplementation | 17.2 | 0 | 1 |
| Category:Aesthetic medicine | 17.2 | 0 | 1 |
| conservative management | 17.2 | 0 | 1 |
| hyaluronic acid binding | 17.2 | 0 | 1 |
| glycosaminoglycan metabolic process | 17.2 | 0 | 1 |
| hyaluronan metabolic process | 17.2 | 0 | 1 |
| hyaluronan catabolic process | 17.2 | 0 | 1 |
| hyaluronan biosynthetic process | 17.2 | 0 | 1 |
| RAC1 | 17.2 | 0 | 1 |
| Rac family small GTPase 1 | 17.2 | 0 | 1 |
| Jesús Usón Center for Minimally Invasion Surgery | 17.2 | 0 | 1 |
| botulinum toxin Type B | 17.2 | 0 | 1 |
| Journal of Minimally Invasive Gynecology | 17.2 | 0 | 1 |
| Minimally Invasive Neurosurgery | 17.2 | 0 | 1 |
| Minimally Invasive Therapy and Allied Technologies | 17.2 | 0 | 1 |
| What to Expect When No One's Expecting | 17.2 | 0 | 1 |
| Q15854197 | 17.2 | 0 | 1 |
| International Association for Physicians in Aesthetic Medicine | 17.2 | 0 | 1 |
| J. D. Sheffield | 17.2 | 0 | 1 |
| What to Expect When Bart's Expecting | 17.2 | 0 | 1 |
| Henry Gustav Beyer | 17.2 | 0 | 1 |
| Minimally invasive adenocarcinoma of the lung | 17.2 | 0 | 1 |
| Botulinum toxin therapy of strabismus | 17.2 | 0 | 1 |
| ClickBus | 17.2 | 0 | 1 |
| injectable filler | 17.2 | 0 | 1 |
| interventional ultrasonography | 17.2 | 0 | 1 |
| Minimally invasive direct coronary artery bypass surgery | 17.2 | 0 | 1 |
| Martin Elliott | 17.2 | 0 | 1 |
| RAC2 | 17.2 | 0 | 1 |
| RAC3 | 17.2 | 0 | 1 |
| RAC1P4 | 17.2 | 0 | 1 |
| RAC1P1 | 17.2 | 0 | 1 |
| RAC1P5 | 17.2 | 0 | 1 |
| RAC1P2 | 17.2 | 0 | 1 |
| RAC1P3 | 17.2 | 0 | 1 |
| RAC1P7 | 17.2 | 0 | 1 |
| RAC1P8 | 17.2 | 0 | 1 |
| GolfNow | 17.2 | 0 | 1 |
| FromAtoB.com | 17.2 | 0 | 1 |
| Habp4 | 17.2 | 0 | 1 |
| Habp2 | 17.2 | 0 | 1 |
| Gm7770 | 17.2 | 0 | 1 |
| Gm3318 | 17.2 | 0 | 1 |
| foodborne botulism | 17.2 | 0 | 1 |
| bronchiolo-alveolar adenocarcinoma | 17.2 | 0 | 1 |
| Anterior Minimally Invasive Surgery | 17.2 | 0 | 1 |
| William Bevan Lewis | 17.2 | 0 | 1 |
| RAC1P9 | 17.2 | 0 | 1 |
| RAC1P6 | 17.2 | 0 | 1 |
| LOC100133102 | 17.2 | 0 | 1 |
| Dermal filler | 17.2 | 0 | 1 |
| Hyaluronan binding protein 2 | 17.2 | 0 | 1 |
| Rac family small GTPase 2 | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Stabilin 2 | 17.2 | 0 | 1 |
| Sensory trick phenomenon improves motor control in pianists with dystonia: prognostic value of glove-effect | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| Rac family small GTPase 3 | 17.2 | 0 | 1 |
| Use of botulinum toxin-A for musculoskeletal pain in patients with whiplash associated disorders [ISRCTN68653575] | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 2 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 4 | 17.2 | 0 | 1 |
| Intrasulcal electrocorticography in macaque monkeys with minimally invasive neurosurgical protocols | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor (RHAMM) | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Rac family small GTPase 3 | 17.2 | 0 | 1 |
| Rac family small GTPase 2 | 17.2 | 0 | 1 |
| Victor Heiser | 17.2 | 0 | 1 |
| Botulinum toxin is effective and safe for palatal tremor | 17.2 | 0 | 1 |
| Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators | 17.2 | 0 | 1 |
| Q22277747 | 17.2 | 0 | 1 |
| Diviac | 17.2 | 0 | 1 |
| Botulinum Toxin as a Biological Weapon: Medical and Public Health Management | 17.2 | 0 | 1 |
| Properties and use of botulinum toxin and other microbial neurotoxins in medicine | 17.2 | 0 | 1 |
| Hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential: selection of sperm for intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| The pattern of tyrosine phosphorylation in human sperm in response to binding to zona pellucida or hyaluronic acid | 17.2 | 0 | 1 |
| Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. | 17.2 | 0 | 1 |
| Botulinum toxin type B for cervical dystonia | 17.2 | 0 | 1 |
| Laser treatment of drusen to prevent progression to advanced age-related macular degeneration | 17.2 | 0 | 1 |
| Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children | 17.2 | 0 | 1 |
| Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia | 17.2 | 0 | 1 |
| Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia | 17.2 | 0 | 1 |
| Botulinum toxin for subacute/chronic neck pain | 17.2 | 0 | 1 |
| Minimally invasive surgical techniques versus open myomectomy for uterine fibroids | 17.2 | 0 | 1 |
| Minimally invasive discectomy versus microdiscectomy/open discectomy for symptomatic lumbar disc herniation | 17.2 | 0 | 1 |
| Levothyroxine or minimally invasive therapies for benign thyroid nodules | 17.2 | 0 | 1 |
| Botulinum toxin for facial wrinkles | 17.2 | 0 | 1 |
| Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders | 17.2 | 0 | 1 |
| Botulinum toxin for myofascial pain syndromes in adults | 17.2 | 0 | 1 |
| Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults | 17.2 | 0 | 1 |
| Botulinum toxin for masseter hypertrophy | 17.2 | 0 | 1 |
| Botulinum toxin for myofascial pain syndromes in adults | 17.2 | 0 | 1 |
| Minimally invasive versus open surgery for reversal of tubal sterilization | 17.2 | 0 | 1 |
| Minimally invasive surgical techniques versus open myomectomy for uterine fibroids | 17.2 | 0 | 1 |
| Minimally invasive surgery versus radiotherapy/chemoradiotherapy for early-stage oropharyngeal carcinoma | 17.2 | 0 | 1 |
| Treatment of recurrent stress urinary incontinence after failed minimally invasive synthetic suburethral tape surgery in women | 17.2 | 0 | 1 |
| Pharmacological interventions other than botulinum toxin for spasticity after stroke | 17.2 | 0 | 1 |
| Conservative treatment for osteoarthritis of the ankle | 17.2 | 0 | 1 |
| Minimally invasive discectomy versus microdiscectomy/discectomy for symptomatic lumbar disc herniation | 17.2 | 0 | 1 |
| Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity | 17.2 | 0 | 1 |
| Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders | 17.2 | 0 | 1 |
| Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity | 17.2 | 0 | 1 |
| Botulinum toxin for the treatment of strabismus | 17.2 | 0 | 1 |
| Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children | 17.2 | 0 | 1 |
| Botulinum toxin injections for adults with overactive bladder syndrome | 17.2 | 0 | 1 |
| Treatment of recurrent stress urinary incontinence after failed minimally invasive synthetic suburethral tape surgery in women | 17.2 | 0 | 1 |
| Minimally invasive versus open surgery for reversal of tubal sterilization | 17.2 | 0 | 1 |
| Botulinum toxin injections for low-back pain and sciatica | 17.2 | 0 | 1 |
| Heated CO 2 with or without humidification for minimally invasive abdominal surgery | 17.2 | 0 | 1 |
| Botulinum toxin injection for tennis elbow | 17.2 | 0 | 1 |
| Botulinum toxin for subacute/chronic neck pain | 17.2 | 0 | 1 |
| Botulinum toxin for shoulder pain | 17.2 | 0 | 1 |
| Obstetric outcomes and fertility after conservative treatment for cervical intraepithelial lesions | 17.2 | 0 | 1 |
| Botulinum toxin for subacute/chronic neck pain | 17.2 | 0 | 1 |
| Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children | 17.2 | 0 | 1 |
| Laser treatment of drusen to prevent progression to advanced age-related macular degeneration | 17.2 | 0 | 1 |
| Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE) | 17.2 | 0 | 1 |
| Heated CO2 with or without humidification for minimally invasive abdominal surgery | 17.2 | 0 | 1 |
| Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women | 17.2 | 0 | 1 |
| Botulinum toxin A for the prevention of hip dislocation in cerebral palsy | 17.2 | 0 | 1 |
| Botulinum toxin for the treatment of chronic idiopathic constipation | 17.2 | 0 | 1 |
| Botulinum toxin for the treatment of strabismus | 17.2 | 0 | 1 |
| Botulinum toxin for low-back pain | 17.2 | 0 | 1 |
| Botulinum toxin for masseter hypertrophy | 17.2 | 0 | 1 |
| Botulinum toxin for shoulder pain | 17.2 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 17.2 | 0 | 1 |
| Botulinum toxin for masseter hypertrophy | 17.2 | 0 | 1 |
| Botulinum toxin for myofascial pain syndromes in adults | 17.2 | 0 | 1 |
| Botulinum toxin type A and serial casting versus botulinum toxin type A or serial casting in treating equinus gait of children with cerebral palsy | 17.2 | 0 | 1 |
| Botulinum toxin for adult spasticity after stroke or non-progressive brain lesion | 17.2 | 0 | 1 |
| Minimally invasive sling operations for stress urinary incontinence in women | 17.2 | 0 | 1 |
| Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia | 17.2 | 0 | 1 |
| Botulinum toxin injections for adults with overactive bladder syndrome | 17.2 | 0 | 1 |
| External fixation versus conservative treatment for distal radial fractures in adults | 17.2 | 0 | 1 |
| External fixation versus conservative treatment for distal radial fractures in adults | 17.2 | 0 | 1 |
| Botulinum toxin type A therapy for hemifacial spasm | 17.2 | 0 | 1 |
| Botulinum toxin type A versus anticholinergics for cervical dystonia | 17.2 | 0 | 1 |
| Botulinum toxin type A therapy for cervical dystonia | 17.2 | 0 | 1 |
| Surgical versus conservative treatment for acute injuries of the lateral ligament complex of the ankle in adults | 17.2 | 0 | 1 |
| Laser treatment of drusen to prevent progression to advanced age-related macular degeneration | 17.2 | 0 | 1 |
| Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy | 17.2 | 0 | 1 |
| Botulinum toxin type B for cervical dystonia | 17.2 | 0 | 1 |
| Botulinum toxin for the treatment of strabismus | 17.2 | 0 | 1 |
| Botulinum toxin injections for adults with overactive bladder syndrome | 17.2 | 0 | 1 |
| Conservative treatment for closed fifth (small finger) metacarpal neck fractures | 17.2 | 0 | 1 |
| Endoscopic balloon dilatation versus botulinum toxin injection in the management of primary achalasia | 17.2 | 0 | 1 |
| Botulinum toxin injections for the treatment of spasmodic dysphonia | 17.2 | 0 | 1 |
| Botulinum toxin type A therapy for blepharospasm | 17.2 | 0 | 1 |
| Botulinum toxin type A therapy for hemifacial spasm | 17.2 | 0 | 1 |
| Botulinum toxin type A therapy for blepharospasm | 17.2 | 0 | 1 |
| Minimally invasive surgical approaches for total hip arthroplasty in adults with osteoarthritis | 17.2 | 0 | 1 |
| Botulinum toxin type A formulations in focal dystonias | 17.2 | 0 | 1 |
| Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy | 17.2 | 0 | 1 |
| Botulinum toxin type A versus botulinum toxin type B for cervical dystonia | 17.2 | 0 | 1 |
| Botulinum toxin type A versus anticholinergics for cervical dystonia | 17.2 | 0 | 1 |
| Botulinum toxin type B for cervical dystonia | 17.2 | 0 | 1 |
| Botulinum toxin for spasmodic dysphonia | 17.2 | 0 | 1 |
| Botulinum toxin type A versus botulinum toxin type B for cervical dystonia | 17.2 | 0 | 1 |
| Clinical comparability of botulinum toxin type A formulations in focal dystonias | 17.2 | 0 | 1 |
| Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2 | 17.2 | 0 | 1 |
| CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2 | 17.2 | 0 | 1 |
| rac, a novel ras-related family of proteins that are botulinum toxin substrates | 17.2 | 0 | 1 |
| Rac3 | 17.2 | 0 | 1 |
| Rac2 | 17.2 | 0 | 1 |
| Rac1 | 17.2 | 0 | 1 |
| Minimally Invasive Detection of Piscirickettsia salmonis in Cultivated Salmonids via the PCR | 17.2 | 0 | 1 |
| Botulinum toxin and sweating | 17.2 | 0 | 1 |
| Hyaluronic acid in human articular cartilage. Age-related changes in content and size | 17.2 | 0 | 1 |
| Botulinum toxin injection of eye muscles to correct strabismus | 17.2 | 0 | 1 |
| Excimer laser treatment for high and extreme myopia | 17.2 | 0 | 1 |
| A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. | 17.2 | 0 | 1 |
| Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid | 17.2 | 0 | 1 |
| The action of botulinum toxin on the neuro-muscular junction | 17.2 | 0 | 1 |
| Sestamibi Scanning and Minimally Invasive Radioguided Parathyroidectomy Without Intraoperative Parathyroid Hormone Measurement | 17.2 | 0 | 1 |
| Thermal Inactivation of Type E Botulinum Toxin | 17.2 | 0 | 1 |
| Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci | 17.2 | 0 | 1 |
| Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection | 17.2 | 0 | 1 |
| An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions | 17.2 | 0 | 1 |
| A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris | 17.2 | 0 | 1 |
| Conservative treatment of patients with faecal soiling | 17.2 | 0 | 1 |
| Surgery with intraoperative botulinum toxin-A injection for the treatment of large-angle horizontal strabismus: a pilot study | 17.2 | 0 | 1 |
| LOC105491764 | 17.2 | 0 | 1 |
| LOC105481454 | 17.2 | 0 | 1 |
| LOC105486432 | 17.2 | 0 | 1 |
| LOC105496764 | 17.2 | 0 | 1 |
| Nonsurgical treatment of chronic anal fissure: nitroglycerin and dilatation versus nifedipine and botulinum toxin | 17.2 | 0 | 1 |
| Botulinum toxin | 17.2 | 0 | 1 |
| Indocyanine green enhanced near‐infrared laser treatment of murine mammary carcinoma | 17.2 | 0 | 1 |
| Realistic expectations of prepulse inhibition in translational models for schizophrenia research | 17.2 | 0 | 1 |
| Manual therapy as a conservative treatment for adolescent idiopathic scoliosis: a systematic review | 17.2 | 0 | 1 |
| Use of hyaluronic acid fillers for the treatment of the aging face | 17.2 | 0 | 1 |
| Botulinum toxin treatment of "one and a half syndrome" | 17.2 | 0 | 1 |
| Identification of hyaluronic acid binding sites in the extracellular domain of CD44 | 17.2 | 0 | 1 |
| THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES | 17.2 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 17.2 | 0 | 1 |
| Intracellular hyaluronic acid binding protein | 17.2 | 0 | 1 |
| Erratum to: Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment | 17.2 | 0 | 1 |
| Prolonged conservative treatment or 'early' surgery in sciatica caused by a lumbar disc herniation: rationale and design of a randomized trial [ISRCT 26872154] | 17.2 | 0 | 1 |
| Conservative treatment in patients with an acute lumbosacral radicular syndrome: design of a randomised clinical trial [ISRCTN68857256] | 17.2 | 0 | 1 |
| Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment | 17.2 | 0 | 1 |
| Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis | 17.2 | 0 | 1 |
| Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis | 17.2 | 0 | 1 |
| Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action | 17.2 | 0 | 1 |
| Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats | 17.2 | 0 | 1 |
| The minimally invasive open video-assisted approach in surgical thyroid diseases | 17.2 | 0 | 1 |
| Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial | 17.2 | 0 | 1 |
| Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus | 17.2 | 0 | 1 |
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | 17.2 | 0 | 1 |
| Exploring strategies to prevent post-lobectomy space: transient diaphragmatic paralysis using Botulinum toxin type A (BTX-A). | 17.2 | 0 | 1 |
| Incisionless Fritsch otoplasty | 17.2 | 0 | 1 |
| Photodisruption | 17.2 | 0 | 1 |
| Minimally invasive glaucoma surgery | 17.2 | 0 | 1 |
| Q25381010 | 17.2 | 0 | 1 |
| Animals in the Zika virus life cycle: what to expect from megadiverse Latin American countries | 17.2 | 0 | 1 |
| Conservative treatment of low back conditions | 17.2 | 0 | 1 |
| Botulinum toxin for motor and phonic tics in Tourette's syndrome | 17.2 | 0 | 1 |
| Dressings and topical agents containing hyaluronic acid for chronic wound healing | 17.2 | 0 | 1 |
| Minimally Invasive Surgery for the Treatment of Colorectal Cancer | 17.2 | 0 | 1 |
| The development and current status of minimally invasive surgery to manage urological complications after renal transplantation | 17.2 | 0 | 1 |
| Toxin yet not toxic: Botulinum toxin in dentistry | 17.2 | 0 | 1 |
| Role of minimally invasive surgery for adult spinal deformity in preventing complications | 17.2 | 0 | 1 |
| Anesthetic challenges in minimally invasive cardiac surgery: Are we moving in a right direction? | 17.2 | 0 | 1 |
| Applications of botulinum toxin in dentistry: A comprehensive review | 17.2 | 0 | 1 |
| Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials | 17.2 | 0 | 1 |
| Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis | 17.2 | 0 | 1 |
| Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms | 17.2 | 0 | 1 |
| Minimally Invasive Suturectomy and Postoperative Helmet Therapy : Advantages and Limitations | 17.2 | 0 | 1 |
| Minimally invasive surgery for upper gastrointestinal cancer: Our experience and review of the literature | 17.2 | 0 | 1 |
| Simultaneous Minimally Invasive Treatment of Colorectal Neoplasm with Synchronous Liver Metastasis | 17.2 | 0 | 1 |
| The Single-Knot Running Vesicourethral Anastomosis after Minimally Invasive Prostatectomy: Review of the Technique and Its Modifications, Tips, and Pitfalls | 17.2 | 0 | 1 |
| 'Mini, ultra, micro' - nomenclature and cost of these new minimally invasive percutaneous nephrolithotomy (PCNL) techniques | 17.2 | 0 | 1 |
| Literature Review and Comparison of Two Statistical Methods to Evaluate the Effect of Botulinum Toxin Treatment on Gait in Children with Cerebral Palsy | 17.2 | 0 | 1 |
| Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature | 17.2 | 0 | 1 |
| Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity | 17.2 | 0 | 1 |
| Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action | 17.2 | 0 | 1 |
| Minimally invasive surgery for inflammatory bowel disease: Review of current developments and future perspectives | 17.2 | 0 | 1 |
| Minimally invasive surgery for inflammatory bowel disease: Current perspectives | 17.2 | 0 | 1 |
| Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies | 17.2 | 0 | 1 |
| Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction | 17.2 | 0 | 1 |
| Minimally Invasive Techniques and Hybrid Operations for Esophageal Cancer | 17.2 | 0 | 1 |
| Botulinum toxin A for the Treatment of Overactive Bladder | 17.2 | 0 | 1 |
| The Role of Minimally Invasive Plate Osteosynthesis in Rib Fixation: A Review | 17.2 | 0 | 1 |
| How botulinum toxin in neurogenic detrusor overactivity can reduce upper urinary tract damage? | 17.2 | 0 | 1 |
| Open Versus Minimally Invasive Fixation Techniques for Thoracolumbar Trauma: A Meta-Analysis | 17.2 | 0 | 1 |
| Minimally Invasive Techniques to Accelerate the Orthodontic Tooth Movement: A Systematic Review of Animal Studies | 17.2 | 0 | 1 |
| British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin | 17.2 | 0 | 1 |
| Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe? | 17.2 | 0 | 1 |
| Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity | 17.2 | 0 | 1 |
| Minimally invasive glaucoma surgery: current status and future prospects | 17.2 | 0 | 1 |
| Anaesthesia for minimally invasive surgery | 17.2 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 17.2 | 0 | 1 |
| Hyaluronic acid and tendon lesions | 17.2 | 0 | 1 |
| Mediastinal giant parathyroid adenoma-a minimally invasive mediastinal surgical approach for an emergency presentation | 17.2 | 0 | 1 |
| Minimally invasive radical thymectomy | 17.2 | 0 | 1 |
| Minimally invasive mediastinal surgery | 17.2 | 0 | 1 |
| Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes | 17.2 | 0 | 1 |
| The role of botulinum toxin A in treating neurogenic bladder | 17.2 | 0 | 1 |
| Esophageal surgery in minimally invasive era | 17.2 | 0 | 1 |
| Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome | 17.2 | 0 | 1 |
| Minimally Invasive Surgery Combined with Regenerative Biomaterials in Treating Intra-Bony Defects: A Meta-Analysis | 17.2 | 0 | 1 |
| Delayed-type Necrosis after Soft-tissue Augmentation with Hyaluronic Acid | 17.2 | 0 | 1 |
| Natural and Controlled Demineralization for Study Purposes in Minimally Invasive Dentistry | 17.2 | 0 | 1 |
| Treatment of painful bladder syndrome/interstitial cystitis with botulinum toxin A: why isn't it effective in all patients? | 17.2 | 0 | 1 |
| Active surveillance and focal therapy for low-intermediate risk prostate cancer | 17.2 | 0 | 1 |
| Minimally invasive surgical approach to pancreatic malignancies | 17.2 | 0 | 1 |
| Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect | 17.2 | 0 | 1 |
| Minimally invasive thoracic surgery: new trends in Italy | 17.2 | 0 | 1 |
| Botulinum toxin injections for treating neurogenic detrusor overactivity | 17.2 | 0 | 1 |
| Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy | 17.2 | 0 | 1 |
| Botox Therapy in Dentistry: A Review | 17.2 | 0 | 1 |
| Minimally invasive knee arthroplasty: An overview | 17.2 | 0 | 1 |
| Medical devices for restless legs syndrome – clinical utility of the Relaxis pad | 17.2 | 0 | 1 |
| Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm | 17.2 | 0 | 1 |
| Minimally invasive surgery for paediatric inflammatory bowel disease: Personal experience and literature review | 17.2 | 0 | 1 |
| New minimally invasive approaches for cholecystectomy: Review of literature | 17.2 | 0 | 1 |
| Unexpected death in palliative care: what to expect when you are not expecting | 17.2 | 0 | 1 |
| Minimally invasive is the future of left ventricular assist device implantation | 17.2 | 0 | 1 |
| The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | 17.2 | 0 | 1 |
| Noncosmetic uses of botulinum toxin in otolaryngology | 17.2 | 0 | 1 |
| Minimally invasive mitral valve repair through a right minithoracotomy approach | 17.2 | 0 | 1 |
| Canaloplasty: A Minimally Invasive and Maximally Effective Glaucoma Treatment | 17.2 | 0 | 1 |
| Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders | 17.2 | 0 | 1 |
| Minimally invasive-percutaneous surgery - recent developments of the foot surgery techniques | 17.2 | 0 | 1 |
| Nonallergic Eyelid Edema After Botulinum Toxin Type A Injection: Case Report and Review of Literature | 17.2 | 0 | 1 |
| Percutaneous and minimally invasive approaches to mitral valve repair for severe mitral regurgitation-new devices and emerging outcomes | 17.2 | 0 | 1 |
| Current concepts on osteonecrosis of the femoral head | 17.2 | 0 | 1 |
| Minimally invasive surgery for congenital diaphragmatic hernia: a meta-analysis | 17.2 | 0 | 1 |
| Minimally Invasive Versus Open Total Gastrectomy for Gastric Cancer: A Systematic Review and Meta-analysis of Short-Term Outcomes and Completeness of Resection : Surgical Techniques in Gastric Cancer | 17.2 | 0 | 1 |
| Development of Facial Rejuvenation Procedures: Thirty Years of Clinical Experience with Face Lifts | 17.2 | 0 | 1 |
| The Basic Conservative Treatment of Temporomandibular Joint Anterior Disc Displacement Without Reduction--Review | 17.2 | 0 | 1 |
| Peroral endoscopic myotomy: An emerging minimally invasive procedure for achalasia | 17.2 | 0 | 1 |
| Transoral robotic thyroid surgery | 17.2 | 0 | 1 |
| Minimally invasive parathyroid surgery | 17.2 | 0 | 1 |
| Review of Pure Endoscopic Full-Thickness Resection of the Upper Gastrointestinal Tract | 17.2 | 0 | 1 |
| Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis | 17.2 | 0 | 1 |
| A comparison of surgical procedures and postoperative cares for minimally invasive laparoscopic gastrectomy and open gastrectomy in gastric cancer | 17.2 | 0 | 1 |
| Is minimally invasive esophagectomy effective for preventing anastomotic leakages after esophagectomy for cancer? A systematic review and meta-analysis | 17.2 | 0 | 1 |
| The effects of laser treatment in tendinopathy: a systematic review | 17.2 | 0 | 1 |
| Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update | 17.2 | 0 | 1 |
| Botulinum Toxin for Neuropathic Pain: A Review of the Literature | 17.2 | 0 | 1 |
| Minimally invasive mitral valve repair using a semi-rigid annuloplasty ring with a new chordal sizing system: the Memo3D ReChord | 17.2 | 0 | 1 |
| The Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee Pain | 17.2 | 0 | 1 |
| Minimally Invasive Microsurgery for Cerebral Aneurysms | 17.2 | 0 | 1 |
| Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature | 17.2 | 0 | 1 |
| Low Back Pain: Current Surgical Approaches | 17.2 | 0 | 1 |
| Minimally invasive pancreatic surgery - a review | 17.2 | 0 | 1 |
| Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection | 17.2 | 0 | 1 |
| Grossesse sur cicatrice de césarienne: à propos d’un cas et revue de la littérature | 17.2 | 0 | 1 |
| Urologic applications of botulinum toxin | 17.2 | 0 | 1 |
| Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins | 17.2 | 0 | 1 |
| Minimally invasive spleen-preserving distal pancreatectomy: Does splenic vessel preservation have better postoperative outcomes? A systematic review and meta-analysis | 17.2 | 0 | 1 |
| An up-to-date overview of minimally invasive treatment methods in ureteropelvic junction obstruction | 17.2 | 0 | 1 |
| Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation | 17.2 | 0 | 1 |
| Endoscopic botox injections in therapy of refractory gastroparesis | 17.2 | 0 | 1 |
| Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation | 17.2 | 0 | 1 |
| Minimally invasive emergent techniques in obesity treatment | 17.2 | 0 | 1 |
| Learning what to expect (in visual perception) | 17.2 | 0 | 1 |
| The eye and visual system in pregnancy, what to expect? An in-depth review | 17.2 | 0 | 1 |
| Minimally invasive approaches for the correction of adult spinal deformity | 17.2 | 0 | 1 |
| Robotic right colectomy for hemorrhagic right colon cancer: a case report and review of the literature of minimally invasive urgent colectomy | 17.2 | 0 | 1 |
| Do Minimally Invasive Approaches Improve Outcomes of Heart Valve Surgery? | 17.2 | 0 | 1 |
| Economic impact of minimally invasive lumbar surgery | 17.2 | 0 | 1 |
| Clinical Relevance of Botulinum Toxin Immunogenicity | 17.2 | 0 | 1 |
| Infection prevention and the medical director: uncharted territory | 17.2 | 0 | 1 |
| The protein-sparing modified fast for obese patients with type 2 diabetes: What to expect | 17.2 | 0 | 1 |
| Responsiveness of quality of life instruments for the comparison of minimally invasive cholecystectomy procedures | 17.2 | 0 | 1 |
| Perspectives of nanotechnology in minimally invasive therapy of breast cancer | 17.2 | 0 | 1 |
| What is the optimal revascularization technique for isolated disease of the left anterior descending artery: minimally invasive direct coronary artery bypass or percutaneous coronary intervention?: Table 1: | 17.2 | 0 | 1 |
| Expert consensus for thermal ablation of primary and metastatic lung tumors | 17.2 | 0 | 1 |
| Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid | 17.2 | 0 | 1 |
| Diagnosis and Treatment of Dystonia | 17.2 | 0 | 1 |
| Minimally Invasive Surgery | 17.2 | 0 | 1 |
| Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the present | 17.2 | 0 | 1 |
| Minimally invasive local treatments for bone and pulmonary metastases | 17.2 | 0 | 1 |
| Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review | 17.2 | 0 | 1 |
| Development of minimally invasive techniques for management of medically-complicated obesity | 17.2 | 0 | 1 |
| Use of (99m)Tc 2-methoxyisobutyl isonitrile in minimally invasive radioguided surgery in patients with primary hyperparathyroidism: A narrative review of the current literature | 17.2 | 0 | 1 |
| The role of the robotic technique in minimally invasive surgery in rectal cancer | 17.2 | 0 | 1 |
| Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis | 17.2 | 0 | 1 |
| From the Idea to Its Realization: The Evolution of Minimally Invasive Techniques in Neurosurgery | 17.2 | 0 | 1 |
| Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee | 17.2 | 0 | 1 |
| State-of-the-Art management of knee osteoarthritis | 17.2 | 0 | 1 |
| Minimally invasive mitral valve surgery: current status | 17.2 | 0 | 1 |
| Minimally invasive surgery for gastric cancer | 17.2 | 0 | 1 |
| Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery | 17.2 | 0 | 1 |
| Coacervate delivery systems for proteins and small molecule drugs | 17.2 | 0 | 1 |
| Managing knee ostheoarthritis: efficacy of hyaluronic acid injections | 17.2 | 0 | 1 |
| Standard terms, definitions, and policies for minimally invasive resection of thymoma | 17.2 | 0 | 1 |
| Minimally invasive mitral valve procedures: the current state | 17.2 | 0 | 1 |
| Minimally invasive treatment of pancreatic pseudocysts | 17.2 | 0 | 1 |
| Minimal invasive approaches in metastatic spinal tumors | 17.2 | 0 | 1 |
| Minimally invasive surgery of the anterior skull base: transorbital approaches | 17.2 | 0 | 1 |
| Hyaluronic Acid and Wound Healing | 17.2 | 0 | 1 |
| Advances in bio-tactile sensors for minimally invasive surgery using the fibre Bragg grating force sensor technique: a survey | 17.2 | 0 | 1 |
| Hyaluronic acid hydrogels for vocal fold wound healing | 17.2 | 0 | 1 |
| Minimally invasive surgical management of benign breast lesions | 17.2 | 0 | 1 |
| Botulinum toxin injection for facial wrinkles | 17.2 | 0 | 1 |
| The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review | 17.2 | 0 | 1 |
| Minimally invasive treatment of ureterovaginal fistula: A review and report of a new technique | 17.2 | 0 | 1 |
| Unfavourable results in facial rejuvenation surgery: How to avoid them | 17.2 | 0 | 1 |
| Surgical management and minimally invasive approaches for the treatment of metastatic sarcoma | 17.2 | 0 | 1 |
| Minimally Invasive versus Open Posterior Lumbar Interbody Fusion: A Systematic Review | 17.2 | 0 | 1 |
| Minimally invasive surgery in gastrointestinal cancer: benefits, challenges, and solutions for underutilization | 17.2 | 0 | 1 |
| Minimally invasive intrathoracic anastomosis after Ivor Lewis esophagectomy for cancer: a review of transoral or transthoracic use of staplers | 17.2 | 0 | 1 |
| Minimally invasive splenectomy: an update and review | 17.2 | 0 | 1 |
| Minimally invasive treatment of pancreatic necrosis | 17.2 | 0 | 1 |
| The self-adjusting file (SAF) system: An evidence-based update | 17.2 | 0 | 1 |
| Nanoscale biofunctionalization of polymer surfaces by laser treatment for controlled cellular differentiation | 17.2 | 0 | 1 |
| Minimally Invasive Surgery for Esophageal Cancer: Review of the Literature and Institutional Experience | 17.2 | 0 | 1 |
| Minimally invasive cardiac surgery and transesophageal echocardiography | 17.2 | 0 | 1 |
| Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies | 17.2 | 0 | 1 |
| Comparative Outcomes of Minimally Invasive Surgery for Posterior Lumbar Fusion: A Systematic Review | 17.2 | 0 | 1 |
| Cervicofacial subcutaneous emphysema associated with dental laser treatment | 17.2 | 0 | 1 |
| Minimally invasive valve sparing mitral valve repair-the loop technique-how we do it | 17.2 | 0 | 1 |
| A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia | 17.2 | 0 | 1 |
| Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis | 17.2 | 0 | 1 |
| Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approaches | 17.2 | 0 | 1 |
| Botulinum Toxin in the Treatment of Muscle Specific Oro-Facial Pain: A Literature Review | 17.2 | 0 | 1 |
| Minimally invasive root surgery: a Bentall procedure through a J-ministernotomy | 17.2 | 0 | 1 |
| Conservative treatment modalities in retinoblastoma | 17.2 | 0 | 1 |
| Therapeutic applications of botulinum neurotoxins in head and neck disorders | 17.2 | 0 | 1 |
| Laser treatment of port-wine stains | 17.2 | 0 | 1 |
| Minimally invasive aortic valve replacement using the Perceval S sutureless valve | 17.2 | 0 | 1 |
| Minimally invasive fetal therapy for hydropic lung masses: three different approaches and review of the literature | 17.2 | 0 | 1 |
| Minimally Invasive Midvastus versus Standard Parapatellar Approach in Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials | 17.2 | 0 | 1 |
| Minimally invasive rapid deployment Edwards Intuity aortic valve implantation | 17.2 | 0 | 1 |
| Nucleoplasty, a minimally invasive procedure for disc decompression: a systematic review and meta-analysis of published clinical studies | 17.2 | 0 | 1 |
| Targeted microbubbles: a novel application for the treatment of kidney stones | 17.2 | 0 | 1 |
| hyaluronan | 17.2 | 0 | 1 |
| beta-D-GlcpA-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpA-(1->3)-D-GlcpNAc | 17.2 | 0 | 1 |
| Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model | 17.2 | 0 | 1 |
| Development of Cutting and Suction Device with Twist Blade Screw for Minimally Invasive Surgery: Evaluation of Suction Performance | 17.2 | 0 | 1 |
| Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens | 17.2 | 0 | 1 |
| Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation | 17.2 | 0 | 1 |
| Combined 2D and 3D tracking of surgical instruments for minimally invasive and robotic-assisted surgery | 17.2 | 0 | 1 |
| Traumatic Hallux Varus Treated by Minimally Invasive Extensor Hallucis Brevis Tenodesis | 17.2 | 0 | 1 |
| Shaeer's Technique: A Minimally Invasive Procedure for Monsplasty and Revealing the Concealed Penis | 17.2 | 0 | 1 |
| Perpendicular Strut Injection of Hyaluronic Acid Filler for Deep Wrinkles | 17.2 | 0 | 1 |
| "Non-Toxic" Proteins of the Botulinum Toxin Complex Exert In-vivo Toxicity | 17.2 | 0 | 1 |
| Minimally invasive subpial tonsillectomy for Chiari I decompression | 17.2 | 0 | 1 |
| Epidemiology and treatment of 23 musicians with task specific tremor | 17.2 | 0 | 1 |
| Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution | 17.2 | 0 | 1 |
| Hyaluronic acid: molecular conformations and interactions in two sodium salts | 17.2 | 0 | 1 |
| Hyaluronic acid: Structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms | 17.2 | 0 | 1 |
| Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A | 17.2 | 0 | 1 |
| What is the role of minimally invasive surgery in a fast track hip and knee replacement pathway? | 17.2 | 0 | 1 |
| Minimally invasive treatment of varicose veins: Endovenous laser ablation (EVLA) | 17.2 | 0 | 1 |
| Early pharmacologic treatment with botulinum toxin A in post-stroke spasticity: consensus evidence-based recommendations | 17.2 | 0 | 1 |
| Conformational divergence in the HA-33/HA-17 trimer of serotype C and D botulinum toxin complex | 17.2 | 0 | 1 |
| Minimally invasive surgical nursing | 17.2 | 0 | 1 |
| Medical laser application : international journal for laser treatment and research | 17.2 | 0 | 1 |
| ISRN minimally invasive surgery | 17.2 | 0 | 1 |
| OA minimally invasive surgery | 17.2 | 0 | 1 |
| Hyaluronic acid: The role of divalent cations in conformation and packing | 17.2 | 0 | 1 |
| Minimally Invasive Surgery for Early-Stage Lung Cancer: From Innovation to Standard of Care | 17.2 | 0 | 1 |
| Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management | 17.2 | 0 | 1 |
| Minimally invasive management of anastomotic leaks in colorectal surgery | 17.2 | 0 | 1 |
| Stereotactic Laser Ablation for Medically Intractable Epilepsy: The Next Generation of Minimally Invasive Epilepsy Surgery | 17.2 | 0 | 1 |
| Clinical innovations in minimally invasive surgery in Korea | 17.2 | 0 | 1 |
| Minimally invasive surgery in management of renal tumours in children | 17.2 | 0 | 1 |
| Botulinum Toxin A for Controlling Obesity | 17.2 | 0 | 1 |
| Instrumentation for minimally invasive surgery in pediatric urology | 17.2 | 0 | 1 |
| History of Botulinum Toxin Treatment in Movement Disorders | 17.2 | 0 | 1 |
| Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy | 17.2 | 0 | 1 |
| Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis | 17.2 | 0 | 1 |
| Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review | 17.2 | 0 | 1 |
| Pancreatic cancer: Open or minimally invasive surgery? | 17.2 | 0 | 1 |
| Clinical Aspects of the Use of Botulinum Toxin Type A in the Treatment of Dysfunction of the Masticatory System | 17.2 | 0 | 1 |
| Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis | 17.2 | 0 | 1 |
| Pediatric anesthesia for minimally invasive surgery in pediatric urology | 17.2 | 0 | 1 |
| Current Role of Minimally Invasive Radical Cholecystectomy for Gallbladder Cancer | 17.2 | 0 | 1 |
| Minimally invasive surgery for stomach cancer | 17.2 | 0 | 1 |
| Advances in minimally invasive neonatal colorectal surgery | 17.2 | 0 | 1 |
| Minimally invasive image-guided therapies for hepatocellular carcinoma | 17.2 | 0 | 1 |
| Pyeloplasty techniques using minimally invasive surgery (MIS) in pediatric patients | 17.2 | 0 | 1 |
| Effectiveness of minimally invasive surgical procedures in the acceleration of tooth movement: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Minimally invasive surgery of diabetic foot - review of current techniques | 17.2 | 0 | 1 |
| A Technical Review of Minimally Invasive Mitral Valve Replacements | 17.2 | 0 | 1 |
| Volumetric techniques: three-dimensional midface modeling | 17.2 | 0 | 1 |
| Fertility sparing treatment in borderline ovarian tumours | 17.2 | 0 | 1 |
| Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery | 17.2 | 0 | 1 |
| Hyaluronic Acid: Perspectives in Upper Aero-Digestive Tract. A Systematic Review | 17.2 | 0 | 1 |
| Shifting Paradigms in Minimally Invasive Surgery: Applications of Transanal Natural Orifice Transluminal Endoscopic Surgery in Colorectal Surgery | 17.2 | 0 | 1 |
| Recent developments in laser treatment of diabetic retinopathy | 17.2 | 0 | 1 |
| Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception | 17.2 | 0 | 1 |
| Effectiveness of hyaluronic acid administration in treating adhesive capsulitis of the shoulder: a systematic review of randomized controlled trials | 17.2 | 0 | 1 |
| Minimally invasive treatment of infected pancreatic necrosis | 17.2 | 0 | 1 |
| Botulinum toxin: An effective treatment for prosthesis-related hyperhidrosis in patients with traumatic amputations | 17.2 | 0 | 1 |
| Ministernotomy or minithoracotomy for minimally invasive aortic valve replacement: a Bayesian network meta-analysis | 17.2 | 0 | 1 |
| Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation | 17.2 | 0 | 1 |
| CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration | 17.2 | 0 | 1 |
| Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells | 17.2 | 0 | 1 |
| Evaluation of Minimally Invasive Therapies and Rationale for a Prospective Randomized Trial to Evaluate Selective Intra-arterial Lysis for Clinically Complete Central Retinal Artery Occlusion | 17.2 | 0 | 1 |
| Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors | 17.2 | 0 | 1 |
| Conservative treatment in an infant with superior vena cava syndrome after cardiac surgery | 17.2 | 0 | 1 |
| Coronary aneurysms not associated to stenosis of coronary arteries. Conservative treatment and evolution in six patients | 17.2 | 0 | 1 |
| Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment | 17.2 | 0 | 1 |
| A new device for minor bleeding control and blunt dissection in minimally invasive surgery | 17.2 | 0 | 1 |
| Appropriate invasive and conservative treatment approaches for patients with ST-elevation MI | 17.2 | 0 | 1 |
| Prospective analysis of conservative treatment of acute coronary syndrome | 17.2 | 0 | 1 |
| Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations | 17.2 | 0 | 1 |
| Comparative analysis of the efficacy of some methods of conservative treatment of accomodation spasms and myopia in children | 17.2 | 0 | 1 |
| Modified constraint-induced therapy and botulinum toxin A: a promising combination | 17.2 | 0 | 1 |
| Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions | 17.2 | 0 | 1 |
| Botox treatment in adductor spasmodic dysphonia: a meta-analysis | 17.2 | 0 | 1 |
| A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement | 17.2 | 0 | 1 |
| Minimally invasive total disc replacement: surgical technique and preliminary clinical results | 17.2 | 0 | 1 |
| A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial | 17.2 | 0 | 1 |
| Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach") | 17.2 | 0 | 1 |
| Magnetic Vascular Port in minimally invasive direct coronary artery bypass grafting | 17.2 | 0 | 1 |
| Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland | 17.2 | 0 | 1 |
| Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin- an effective treatment for acquired nystagmus with oscillopsia | 17.2 | 0 | 1 |
| Treatment of wrinkles with botulinum toxin | 17.2 | 0 | 1 |
| Q28222294 | 17.2 | 0 | 1 |
| Conservative treatment of lymphoedema of the limbs | 17.2 | 0 | 1 |
| Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections | 17.2 | 0 | 1 |
| Treatment of unilateral acute sixth-nerve palsy with botulinum toxin | 17.2 | 0 | 1 |
| Minimally invasive resection of papillary fibroelastoma in a high-risk patient | 17.2 | 0 | 1 |
| Evidence for minimally invasive therapies in the management of chronic calcific tendinopathy of the rotator cuff: a systematic review and meta-analysis | 17.2 | 0 | 1 |